title: Match unrelated bone marrow transplantation in a case of high risk myelodysplastic syndrome treated with azacitidine and concomitant 1alpha-25-dihydroxyvitamin D3, as differentiating agent.
authors.forename: Enrico
authors.initials: E
authors.lastname: Orciuolo
authors.forename: Nadia
authors.initials: N
authors.lastname: Cecconi
authors.forename: Sara
authors.initials: S
authors.lastname: Galimberti
authors.forename: Federico
authors.initials: F
authors.lastname: Papineschi
authors.forename: Mario
authors.initials: M
authors.lastname: Petrini
mesh_terms: D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D001374:Azacitidine / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D002454:Cell Differentiation / Q000187:drug effects*; D005260:Female; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000628:therapy*; D014807:Vitamin D / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000964:Antimetabolites, Antineoplastic; C118756:dihydroxy-vitamin D3; D014807:Vitamin D; D001374:Azacitidine